Skip to main content
. 2018 May 15;7(7):3269–3277. doi: 10.1002/cam4.1544

Table 4.

Associations between age at diagnosis and breast cancer recurrence

Models n/event Hazards ratio (95% CI) c‐index
40‐59 ~39 60~
Model 1 880/86 1.00 (reference) 2.96 (1.54, 5.67) 1.93 (1.21, 3.08) 0.61
Model 2 822/81 1.00 (reference) 2.81 (1.44, 5.45) 2.37 (1.45, 3.89) 0.68
Model 3 537/57 1.00 (reference) 2.51 (1.28, 4.89) 2.49 (1.51, 4.10) 0.71
Model 4 537/57 1.00 (reference) 2.22 (1.06, 4.65) 1.84 (1.03, 3.37) 0.69
Model 5 535/57 1.00 (reference) 1.97 (0.94, 4.17) 2.03 (1.11, 3.74) 0.71
Model 6 503/52 1.00 (reference) 1.93 (0.85, 4.39) 2.11 (1.13, 3.40) 0.70
Model 7 503/52 1.00 (reference) 1.89 (0.84, 4.29) 2.11 (1.13, 3.96) 0.70
Model 8 503/52 1.00 (reference) 1.84 (0.81, 4.20) 2.15 (1.15, 4.04) 0.70
Model 9 503/52 1.00 (reference) 1.93 (0.85, 4.34) 2.12 (1.13, 3.97) 0.70
Model 10 503/52 1.00 (reference) 1.85 (0.82, 4.23) 2.12 (1.13, 3.98) 0.70
Model 11 503/52 1.00 (reference) 1.89 (0.83, 4.28) 2.17 (1.16, 4.07) 0.70
Model 12 503/52 1.00 (reference) 1.87 (0.81, 4.32) 2.13 (1.13, 4.03) 0.70

Model 1, unadjusted; Model 2, adjusted by race, tumor size, node status; Model 3, further adjusted by PAM50 subtype; Model 4, further adjusted by risk stratification; Model 5, further adjusted by DNAm age; Model 6‐11, further separately adjusted by GATA 3, PIK3CA, MLL3, CDH1, TP53, MAP3K1; Model 12 adjusted all the variables.